Retrovirology

official impact factor 5.24

This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology

Open Access Poster presentation

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia

Snjezana Z Lepej1*, Anica Remenar1, Ela Kosor2, Alenka Gagro2 and Josip Begovac3

Author Affiliations

1 Division of Cellular Immunology, University Hospital for Infectious Diseases, Zagreb, Croatia

2 Department for Research and Development, Institute of Immunology, Zagreb, Croatia

3 Croatian Refferal Center for AIDS, University Hospital for Infectious Diseases, Zagreb, Croatia

For all author emails, please log on.

Retrovirology 2005, 2(Suppl 1):P1 doi:10.1186/1742-4690-2-S1-P1

Published: 8 December 2005

First paragraph (this article has no abstract)

HIV-specific CD8+ T-cells in the peripheral blood diminish in most patients after the initiation of highly active antiretroviral therapy (HAART). However, examples of de novo appearance of HIV-specific CD8+ T-cells in patients with long-term successful therapy have also been described. The aim of our study was to determine the frequency and absolute counts of Gag-specific CD8+ T-cells in the peripheral blood of HIV-patients with more than 5 years of treatment-induced undetectable viremia and compare it with non-symptomatic untreated chronically-infected persons.